Paul D'Angio
Director/Board Member at NEXIMMUNE, INC.
Net worth: 3 795 $ as of 29/04/2024
Network origin in Paul D'Angio first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 14 | |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
13
| Extinct | Biotechnology | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paul D'Angio via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| ACASTI PHARMA INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder | |
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| American University | College/University | Graduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
| The State University of New York | College/University | Corporate Officer/Principal Doctorate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| Semorex, Inc. | Director/Board Member Director/Board Member | ||
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| NETSCIENTIFIC PLC | Medical Specialties | Chairman Chief Executive Officer | |
| CONTRAFECT CORPORATION | Biotechnology | Chairman Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
| CancerCare of New Jersey | Director/Board Member | ||
| INSPIREMD, INC. | Medical Specialties | Chairman Director/Board Member | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| ARVINAS, INC. | Biotechnology | Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Director/Board Member | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Zephyr Ai, Inc.
 Zephyr Ai, Inc. Packaged SoftwareTechnology Services Zephyr Ai, Inc. is a healthcare technology company based in Dallas, TX. Zephyr Ai is committed to revolutionizing drug discovery and precision medicine through partnerships and proprietary data. The company curates the world's most comprehensive healthcare dataset and uses cutting-edge artificial intelligence algorithms to generate novel insights that support patients, providers, and ongoing research. The company was founded in 2020 by Grant Lovely VerStandig, Jeff Sherman, and Yisroel Brumer. David L. Morgan has been the CEO of the company since 2022. | Packaged Software | Director/Board Member Founder | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| CERTARA, INC. | Packaged Software | Director/Board Member General Counsel | |
| ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Director/Board Member | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 42 |
| Israel | 4 |
| United Kingdom | 4 |
| France | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Technology Services | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 250 |
| Corporate Officer/Principal | 105 |
| Independent Dir/Board Member | 90 |
| Chairman | 73 |
| Founder | 41 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Jerome Zeldis | 38 |
| Richard Sykes | 37 |
| Sol Barer | 32 |
| Liam Ratcliffe | 32 |
| Robert Spiegel | 30 |
| Rosemary Crane | 23 |
| Kamil Ali-Jackson | 21 |
| Ilian Iliev | 21 |
| Alan Roemer | 21 |
| Stephen Glover | 19 |
| Kenneth Carter | 18 |
| Grant Verstandig | 17 |
| Gregory Freitag | 16 |
| W. Middlekauff | 14 |
- Stock Market
- Insiders
- Paul D'Angio
- Company connections
